Drugs / Technetium [99mTc]-H7ND
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07107633 | Mar → Sep 2025 overdue | peritoneal carcinomatosis | Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Technetium [99mTc]-H7ND | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07107633 ↗ |
| Action | Inhibit | “fibroblast activation protein inhibitor” NCT07107633 ↗ |